4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-carbaldehyde, 97%, 1g

(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid, 98.0%, 1g

1-Benzyl-5-(trifluoromethyl)-1H-pyrazole-3-carboxylic acid, >95%, 1g

3-(trifluoromethyl)piperidin-3-ol hydrochloride, 95.0%, 1g

N-(tert-butyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide, 5g

4,6-difluoro-N-((tetrahydrofuran-2-yl)methyl)benzo[d]thiazol-2-amine, 95.0%, 250mg

D-glucuronic acid, min. 98%, for biochemistry, 10 g, glass packaging

7-Azaspiro[3.5]nonan-2-ol hydrochloride, 95.0%, 10g

4-CHLORO-6-(METHYLSULFONYL)PYRIMIDINE, 95%, 100mg

4-Allyloxy-benzoic acid, 95%, 1g

2-Chloro-4-vinylpyrimidine, 97%, 5g

5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole, 95.0%, 5mg

Ethyl 2-methyl-4-oxocyclohex-2-enecarboxylate, 95.0%, 25g